Advanced search×

Sixth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, 16-18 October 2008.

Michele M Maio, Hugues J M HJ Nicolay, Paolo A PA Ascierto, Filippo F Belardelli, Roberto R Camerini, Mario P MP Colombo, Paola P Queirolo, Ruggero R Ridolfi, Vincenzo V Russo, Ester E Fonsatti, Giorgio G Parmiani, and

Cancer Immunol Immunother 59(6):963-9 (2010) PMID 19330329

DOI: 10.1007/s00262-009-0696-5
Version: za2963e q8zac q8zbb q8zc4 q8zd6 q8ze0 q8zf1 q8zg4

Similar articles you may find interesting…

  1. Surgical strategy in a kindred with a rare RET protooncogene mutation of variable penetrance with regard to multiple endocrine neoplasia.
    Mario M Colombo-Benkmann, Jürgen J Brämswig, ... Norbert N Senninger

    World J Surg 26(10):1286-90 (2002) PMID 12205548

    Prophylactic thyroidectomy is recommended for carriers of RET protooncogene mutations owing to their nearly complete penetrance for medullary thyroid carcinoma (MTC). However, this guideline is challenged by mutations exhibiting variable penetrance of C-cell pathology. A 38-year-old woman presented...
  2. Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma.
    Umberto Capitanio, Claudio Jeldres, ... Pierre I Karakiewicz

    BJU Int 103(1):33-7 (2009) PMID 18990161

    From the prognostic perspective, staging lymphadenectomy appears of most value in patients with T1-2 RCC, but the low prevalence of eNM questions the practical applicability of nodal staging in those patients. Conversely, in patients with T3 RCC, the prevalence and the prognostic impact of eNM might...
  3. Compound heterozygosity for a novel and a recurrent ABCC6 gene mutation in an Italian family with Pseudoxanthoma elasticum
    Bruno B Drera, Andrea A Brezzi, ... Marina M Colombi

    J Dermatol Sci 49(3):4 (2008) PMID 18029147